Health and Fitness
Source: (remove) : ELLE
RSS • JSON • XML • CSV
Health and Fitness
Source: (remove) : ELLE
RSS • JSON • XML • CSV

The 'Ozempic Dupes' Are Coming, and They Might Work Even Better


Published on 2025-03-13 08:23:20 - ELLE
  Print publication without navigation

  • Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently suggested that investments in weight-loss drugs would be better spent simply delivering three healthy meals to people every day.

The article from Elle discusses the rise of GLP-1 agonists like Ozempic, originally developed for managing type 2 diabetes, now being used off-label for weight loss due to their effectiveness in reducing appetite and promoting weight loss. These medications mimic the GLP-1 hormone, which helps in slowing digestion, increasing insulin, and reducing hunger. The popularity of these drugs has surged, leading to shortages and a broader conversation about their use for cosmetic weight loss. The article highlights the potential side effects, the ethical considerations of using diabetes medication for weight loss, and the societal implications of seeking quick fixes for weight management. It also touches on the pharmaceutical industry's response with new drugs like Wegovy, specifically approved for weight loss, and the ongoing debate about the long-term effects and the psychological impact of relying on such medications.

Read the Full ELLE Article at:
[ https://www.elle.com/beauty/health-fitness/a63435797/ozempic-glp-1-weight-loss-pills-explained/ ]